TRE has been readily adoptable in the populations with central obesity and resulted in reducing body weight, waist circumference, feeling of hunger, ghrelin, systolic BP, and improvements in insulin resistance, glycemic control, oxidative stress, sleep, and well-being [10,36,39,40,41,43]. This evidence concerns the gene GHRL and Abdominal obesity.